Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients
NCT01758939
·
clinicaltrials.gov ↗
UNKNOWN
Status
100000
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C, Chronic
Sponsor
Cairo University